表紙
市場調查報告書
商品編碼
1040199

血液分析儀市場:按產品/服務、按類型、按最終用戶:全球機會分析和行業預測(2021-2030)

Hematology Analyzer Market by Product & Service, Type, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030.

出版日期: | 出版商: Allied Market Research | 英文 261 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2020年全球血液分析儀市場規模達到19.624億美元。

預計該市場在 2021 年至 2030 年間將以 7.30% 的複合年增長率增長,到 2030 年將達到 39.411 億美元。

推動血液分析儀市場增長的主要因素是貧血、血癌、出血性疾病和血液感染等血液疾病的患病率增加。此外,血液分析儀的技術進步、對自動化血液分析儀的需求不斷增長以及對靈敏血液分析儀的日益偏好正在推動血液分析儀市場的增長。然而,由於先進的功能和自動化導致的高成本會阻礙市場增長。此外,血液分析儀的嚴格監管政策預計將限制市場增長。

本報告調查了全球血液分析儀市場,按產品/服務、類型、最終用戶、地區和進入市場的公司概況提供了市場概況、趨勢

目錄

第 1 章介紹

第 2 章執行摘要

第 3 章市場情況

  • 市場定義和範圍
  • 主要調查結果
    • 主要投資領域
    • 主要成功策略
  • 波特五力分析
  • 2020年各大公司定位
  • 市場動態
    • 促進因素
      • 血液疾病患病率增加
      • 血液分析儀的技術進步
      • 對自動血液分析儀的需求不斷增加,對高靈敏度血液分析儀的偏好日益增加
    • 抑制因素
      • 血液分析儀成本高
      • 嚴格的血液分析儀監管政策
    • 市場機會
      • 新興經濟體的增長機會
    • 影響分析
  • COVID-19 對血液分析儀市場的影響分析

第 4 章血液分析儀市場:按產品/服務

  • 概述
    • 市場規模和預測
  • 設備
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按地區
      • 設備市場規模和預測:按最終用戶
    • 市場分析:按國家/地區
  • 試劑/耗材
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測
      • 試劑和耗材的市場規模和預測:按最終用戶
    • 市場分析:按國家/地區
  • 服務
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測
      • 服務市場規模和預測:按最終用戶
    • 市場分析:按國家/地區

第 5 章血液分析儀市場:按類型

  • 概述
    • 市場規模和預測
  • 全自動血液分析儀
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區
  • 半自動血液分析儀
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區

第 6 章血液分析儀市場:按最終用戶

  • 概述
    • 市場規模和預測
  • 醫院
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區
  • 臨床研究所
    • 市場規模和預測:按地區
    • 市場分析:按國家/地區
  • 研究所
    • 市場規模和預測
    • 市場分析:按國家/地區
  • 其他
    • 市場規模和預測
    • 市場分析:按國家/地區

第 7 章血液分析儀市場:按地區

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
    • 北美市場規模和預測:按產品/服務
    • 北美市場規模和預測:按類型
    • 北美市場規模和預測:按最終用戶
  • 歐洲
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按國家/地區
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 其他
    • 歐洲市場規模和預測:按產品/服務
    • 歐洲市場規模和預測:按類型
    • 歐洲市場規模和預測:按最終用戶
  • 亞太地區
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按國家/地區
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他
    • 亞太市場規模和預測:按產品/服務分類
    • 亞太市場規模和預測:按類型
    • 亞太市場規模和預測:按最終用戶
  • 拉丁美洲、中東、非洲
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測:按國家/地區
      • 巴西
      • 沙特阿拉伯
      • 南非
      • 其他
    • 拉丁美洲、中東、非洲市場規模和預測:按產品/服務分類
    • 拉丁美洲、中東、非洲市場規模和預測:按類型
    • 拉丁美洲、中東、非洲市場規模和預測:按最終用戶

第 8 章公司簡介

  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES, INC.
  • BOULE DIAGNOSTICS AB
  • DANAHER CORPORATION(BECKMAN COULTER INC.)
  • F. HOFFMANN-LA ROCHE AG
  • HORIBA, LTD.
  • NIHON KOHDEN CORPORATION
  • SIEMENS AG
  • STRATEC SE(DIATRON MI PLC)
  • SYSMEX CORPORATION
目錄
Product Code: LI_2113999 / A13630

The global hematology analyzer market was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030.

Hematology is a branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to the blood. Hematology analyzers are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting. Hematology analyzers are used to conduct a complete blood count (CBC), which is usually the first test requested by physicians to determine a patients general health status. A complete blood count includes red blood cell (RBC), white blood cell (WBC), hemoglobin, and platelet counts, as well as hematocrit levels. Other analyses include RBC distribution width, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentrations, WBC differential count in percentage and absolute value, platelet distribution width, platelet mean volume, large platelet cell ratio, platelet criteria.

The main driving factors that drive growth of the hematology analyzer market include, increase in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference towards high sensitivity hematology analyzer further boost the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hamper the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative growth opportunities for players in the hematology analyzer market.

The global hematology analyzer market is segmented on the basis of product & service, type, end user, and region to provide a detailed assessment of the market. By product & service it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully automated hematology analyzer and semi-automated hematology analyzer. Based on end user, it is categorized into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the hematology analyzer market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of hematology analyzer used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product & Service

  • Instruments
  • Reagents & Consumables
  • Services

By Type

  • Fully Automated Hematology Analyzers
  • Semi-automated Hematology Analyzers

By End User

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter Inc.)
  • Bio-Rad Laboratories
  • Boule Diagnostics AB
  • F Hoffmann-La Roche Ltd
  • Hobira Ltd
  • Nihon Kohden Corporation,
  • Siemens Healthineers
  • Stratec SE (Diatron MI Plc.)
  • Sysmex Corporation.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of blood disorders
      • 3.5.1.2.Technological advancements in hematology analyzers
      • 3.5.1.3.Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer
    • 3.5.2.Restraints
      • 3.5.2.1.High cost of hematology analyzers
      • 3.5.2.2.Stringent regulatory policies for hematology analyzers
    • 3.5.3.Opportunities
      • 3.5.3.1.Growth opportunities in emerging economics
    • 3.5.4.Impact analysis
  • 3.6.COVID-19 Impact analysis on the hematology analyzer market

CHAPTER 4:HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Instruments
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
      • 4.2.2.1.Market size and forecast for instruments, by end user
    • 4.2.3.Market analysis, by country
  • 4.3.Reagents and consumables
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
      • 4.3.2.1.Market size and forecast for reagents & consumables, by end user
    • 4.3.3.Market analysis, by country
  • 4.4.Services
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast
      • 4.4.2.1.Market size and forecast for services, by end user
    • 4.4.3.Market analysis, by country

CHAPTER 5:HEMATOLOGY ANALYZER MARKET, BY TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Fully Automated Hematology Analyzer
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Semi-Automated Hematology Analyzer
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country

CHAPTER 6:HEMATOLOGY ANALYZER MARKET, BY END USER

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Hospitals
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Clinical Laboratories
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country
  • 6.4.Research Institutes
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country
  • 6.5.Others
    • 6.5.1.Market size and forecast
    • 6.5.2.Market analysis, by country

CHAPTER 7:HEMATOLOGY ANALYZER MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.Market size and forecast, by country
      • 7.2.2.1.U.S.
      • 7.2.2.1.1.U.S. hematology analyzer market, by product & services
      • 7.2.2.1.2.U.S. hematology analyzer market, by type
      • 7.2.2.1.3.U.S. hematology analyzer market, by end user
      • 7.2.2.2.Canada
      • 7.2.2.2.1.Canada hematology analyzer market, by product & services
      • 7.2.2.2.2.Canada hematology analyzer market, by type
      • 7.2.2.2.3.Canada hematology analyzer market, by end user
      • 7.2.2.3.Mexico
      • 7.2.2.3.1.Mexico hematology analyzer market, by product & services
      • 7.2.2.3.2.Mexico hematology analyzer market, by type
      • 7.2.2.3.3.Mexico hematology analyzer market, by end user
    • 7.2.3.North America market size and forecast, by product & services
    • 7.2.4.North America market size and forecast, by type
    • 7.2.5.North America market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany hematology analyzer market, by product & services
      • 7.3.2.1.2.Germany hematology analyzer market, by type
      • 7.3.2.1.3.Germany hematology analyzer market, by end user
      • 7.3.2.2.France
      • 7.3.2.2.1.France hematology analyzer market, by product & services
      • 7.3.2.2.2.France hematology analyzer market, by type
      • 7.3.2.2.3.France hematology analyzer market, by end user
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK hematology analyzer market, by product & services
      • 7.3.2.3.2.UK hematology analyzer market, by type
      • 7.3.2.3.3.UK hematology analyzer market, by end user
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy hematology analyzer market, by product & services
      • 7.3.2.4.2.Italy hematology analyzer market, by type
      • 7.3.2.4.3.Italy hematology analyzer market, by end user
      • 7.3.2.5.Spain
      • 7.3.2.5.1.Spain hematology analyzer market, by product & services
      • 7.3.2.5.2.Spain hematology analyzer market, by type
      • 7.3.2.5.3.Spain hematology analyzer market, by end user
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe hematology analyzer market, by product & services
      • 7.3.2.6.2.Rest of Europe hematology analyzer market, by type
      • 7.3.2.6.3.Rest of Europe hematology analyzer market, by end user
    • 7.3.3.Europe market size and forecast, by product & services
    • 7.3.4.Europe market size and forecast, by type
    • 7.3.5.Europe market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan hematology analyzer market, by product & services
      • 7.4.2.1.2.Japan hematology analyzer market, by type
      • 7.4.2.1.3.Japan hematology analyzer market, by end user
      • 7.4.2.2.China
      • 7.4.2.2.1.China hematology analyzer market, by product & services
      • 7.4.2.2.2.China hematology analyzer market, by type
      • 7.4.2.2.3.China hematology analyzer market, by end user
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia hematology analyzer market, by product & services
      • 7.4.2.3.2.Australia hematology analyzer market, by type
      • 7.4.2.3.3.Australia hematology analyzer market, by end user
      • 7.4.2.4.India
      • 7.4.2.4.1.India hematology analyzer market, by product & services
      • 7.4.2.4.2.India hematology analyzer market, by type
      • 7.4.2.4.3.India hematology analyzer market, by end user
      • 7.4.2.5.South Korea
      • 7.4.2.5.1.South Korea hematology analyzer market, by Product & services
      • 7.4.2.5.2.South Korea hematology analyzer market, by type
      • 7.4.2.5.3.South Korea hematology analyzer market, by end user
      • 7.4.2.6.Rest of Asia-Pacific
      • 7.4.2.6.1.Rest of Asia-Pacific hematology analyzer market, by product & services
      • 7.4.2.6.2.Rest of Asia-Pacific hematology analyzer market, by type
      • 7.4.2.6.3.Rest of Asia-Pacific hematology analyzer market, by end user
    • 7.4.3.Asia-Pacific market size and forecast, by product & services
    • 7.4.4.Asia-Pacific market size and forecast, by type
    • 7.4.5.Asia-Pacific market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil
      • 7.5.2.1.1.Brazil hematology analyzer market, by product & services
      • 7.5.2.1.2.Brazil hematology analyzer market, by type
      • 7.5.2.1.3.Brazil hematology analyzer market, by end user
      • 7.5.2.2.Saudi Arabia
      • 7.5.2.2.1.Saudi Arabia hematology analyzer market, by product & services
      • 7.5.2.2.2.Saudi Arabia hematology analyzer market, by type
      • 7.5.2.2.3.Saudi Arabia hematology analyzer market, by end user
      • 7.5.2.3.South Africa
      • 7.5.2.3.1.South Africa hematology analyzer market, by product & services
      • 7.5.2.3.2.South Africa hematology analyzer market, by type
      • 7.5.2.3.3.South Africa hematology analyzer market, by end user
      • 7.5.2.4.Rest of LAMEA
      • 7.5.2.4.1.Rest of LAMEA hematology analyzer market, by product & services
      • 7.5.2.4.2.Rest of LAMEA hematology analyzer market, by type
      • 7.5.2.4.3.Rest of LAMEA hematology analyzer market, by end user
    • 7.5.3.LAMEA market size and forecast, by product & services
    • 7.5.4.LAMEA market size and forecast, by type
    • 7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.ABBOTT LABORATORIES
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.BIO-RAD LABORATORIES, INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
  • 8.3.BOULE DIAGNOSTICS AB
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.DANAHER CORPORATION (BECKMAN COULTER INC.)
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
    • 8.4.6.Key strategic moves and developments
  • 8.5.F. HOFFMANN-LA ROCHE AG
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.HORIBA, LTD.
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.NIHON KOHDEN CORPORATION
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
    • 8.7.6.Key strategic moves and developments
  • 8.8.SIEMENS AG
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.STRATEC SE (DIATRON MI PLC)
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
    • 8.9.6.Key strategic moves and developments
  • 8.10.SYSMEX CORPORATION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.GLOBAL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 02.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY REGION, 2020-2030($MILLION)
  • TABLE 03.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY END USER, 2020-2030($MILLION)
  • TABLE 04.HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030($MILLION)
  • TABLE 05.HEMATOLOGY ANALYZER MARKET FOR REAGENTS & CONSUMABLES, BY END USER, 2020-2030($MILLION)
  • TABLE 06.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY REGION, 2020-2030($MILLION)
  • TABLE 07.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY END USER, 2020-2030($MILLION)
  • TABLE 08.GLOBAL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 09.HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
  • TABLE 10.HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
  • TABLE 11.GLOBAL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 12.HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
  • TABLE 13.HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030($MILLION)
  • TABLE 14.HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030($MILLION)
  • TABLE 15.HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
  • TABLE 16.HEMATOLOGY ANALYZER MARKET, BY REGION, 2020-2030($MILLION)
  • TABLE 17.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 18.U.S. HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 19.U.S. HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 20.U.S. HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 21.CANADA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 22.CANADA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 23.CANADA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 24.MEXICO HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 25.MEXICO HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 26.MEXICO HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 27.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 28.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 29.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 30.EUROPE HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 31.GERMANY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 32.GERMANY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 33.GERMANY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 34.FRANCE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 35.FRANCE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 36.FRANCE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 37.UK HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 38.UK HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 39.UK HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 40.ITALY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 41.ITALY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 42.ITALY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 43.SPAIN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 44.SPAIN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 45.SPAIN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 46.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 47.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 48.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 49.EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 50.EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 51.EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 52.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 53.JAPAN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 54.JAPAN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 55.JAPAN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 56.CHINA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 57.CHINA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 58.CHINA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 59.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 60.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 61.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 62.INDIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 63.INDIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 64.INDIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 65.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 66.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 67.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 68.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 69.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 70.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 71.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 72.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 73.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 74.LAMEA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
  • TABLE 75.BRAZIL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 76.BRAZIL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 77.BRAZIL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 78.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 79.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 80.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 81.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 82.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 83.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY END USER 2020-2030($MILLION)
  • TABLE 84.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 85.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 86.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, END USER, 2020-2030($MILLION)
  • TABLE 87.LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
  • TABLE 88.LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
  • TABLE 89.LAMEA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
  • TABLE 90.ABBOTT: COMPANY SNAPSHOT
  • TABLE 91.ABBOTT: OPERATING SEGMENTS
  • TABLE 92.ABBOTT: PRODUCT PORTFOLIO
  • TABLE 93.ABBOTT: KEY DEVELOPMENTS
  • TABLE 94.BIORAD: COMPANY SNAPSHOT
  • TABLE 95.BIORAD: OPERATING SEGMENTS
  • TABLE 96.BIORAD: PRODUCT PORTFOLIO
  • TABLE 97.BOULE: COMPANY SNAPSHOT
  • TABLE 98.BOULE: OPERATING SEGMENTS
  • TABLE 99.BOULE: PRODUCT PORTFOLIO
  • TABLE 100.BOULE: KEY DEVELOPMENTS
  • TABLE 101.DANAHER: COMPANY SNAPSHOT
  • TABLE 102.DANAHER: OPERATING SEGMENTS
  • TABLE 103.DANAHER: PRODUCT PORTFOLIO
  • TABLE 104.DANAHER: KEY DEVELOPMENTS
  • TABLE 105.ROCHE: COMPANY SNAPSHOT
  • TABLE 106.ROCHE: OPEARING SEGMENTS
  • TABLE 107.ROCHE: PRODUCT PORTFOLIO
  • TABLE 108.ROCHE: KEY DEVELOPMENTS
  • TABLE 109.HORIBA: COMPANY SNAPSHOT
  • TABLE 110.HORIBA: OPERATING SEGMENTS
  • TABLE 111.HORIBA: PRODUCT PORTFOLIO
  • TABLE 112.HORIBA: KEY DEVELOPMENTS
  • TABLE 113.NIHON: COMPANY SNAPSHOT
  • TABLE 114.NIHON: OPERATING SEGMENTS
  • TABLE 115.NIHON: PRODUCT PORTFOLIO
  • TABLE 116.NIHON: KEY DEVELOPMENTS
  • TABLE 117.SIEMENS: COMPANY SNAPSHOT
  • TABLE 118.SIEMENS: OPERATING SEGMENTS
  • TABLE 119.SIEMENS: PRODUCT PORTFOLIO
  • TABLE 120.SIEMENS: KEY DEVELOPMENTS
  • TABLE 121.STRATEC: COMPANY SNAPSHOT
  • TABLE 122.STRATEC: OPERATING SEGMENTS
  • TABLE 123.STRATEC: PRODUCT PORTFOLIO
  • TABLE 124.STRATEC: KEY DEVELOPMENTS
  • TABLE 125.SYSMEX: COMPANY SNAPSHOT
  • TABLE 126.SYSMEX: OPERATING SEGMENTS
  • TABLE 127.SYSMEX: PRODUCT PORTFOLIO
  • TABLE 128.SIEMENS: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 01.HEMATOLOGY ANALYZER MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10.HIGH INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 14.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
  • FIGURE 22.ABBOTT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 23.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 24.ABBOTT: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 25.BIORAD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 26.BIORAD: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 27.BIORAD: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 28.BOULE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 29.DANAHER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 30.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 31.DANAHER: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 32.ROCHE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 33.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 34.ROCHE: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 35.HORIBA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 36.HORIBA: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 37.HORIBA: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 38.NIHON: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 39.NIHON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 40.NIHON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 41.SIEMENS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 42.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 43.SIEMENS: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 44.STRATEC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 45.STRATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 46.STRATEC: REVENUE SHARE BY REGION, 2020(%)
  • FIGURE 47.SYSMEX: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 48.SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 49.SYSMEX: REVENUE SHARE BY REGION, 2020(%)